# Soligenix, Inc.: filings

SNGX · Nasdaq · CIK 812796 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sngx.md) · [Financials](/companies/sngx/financials.md) · [Filings](/companies/sngx/filings.md) · [Insiders](/companies/sngx/insiders.md)

## Reports and events: 350 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 231, 8-K 179, 424B3 102, 10-Q 53, EFFECT 47, CORRESP 45, DEFA14A 38, POS AM 28, SC 13D/A 28, UPLOAD 25, S-1/A 24, 3 22, DEF 14A 20, 10-K 18, S-1 16, SC 13G/A 14, PRE 14A 12, 424B5 11, CT ORDER 9, SC 13G 9, 424B4 7, SC 13D 7, D 6, ARS 4, S-3 4, S-3/A 4, S-8 4, 8-K/A 3, SCHEDULE 13G 3, 10-K/A 2, DEFR14A 2, NT 10-Q 2, 25-NSE 1, 8-A12B 1, 8-A12G 1, CERTNAS 1, DRS 1, PRER14A 1, S-1MEF 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 20:30 ET | [8-K](/filings/0001104659-26-109329.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109329 |
| 2026-08-07 | 20:05 ET | [10-Q](/filings/0001104659-26-092681.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092681 |
| 2026-08-03 | 20:05 ET | [DEF 14A](/filings/0001104659-26-089789.md) | Proxy statement, period 2026-09-17 | 0001104659-26-089789 |
| 2026-06-26 | 20:06 ET | [8-K](/filings/0001104659-26-078251.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-078251 |
| 2026-06-12 | 20:05 ET | [8-K](/filings/0001104659-26-073430.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-073430 |
| 2026-05-28 | 21:21 ET | [8-K](/filings/0001104659-26-067649.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-067649 |
| 2026-05-08 | 20:05 ET | [10-Q](/filings/0001104659-26-057904.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057904 |
| 2026-04-28 | 11:30 ET | [8-K](/filings/0001104659-26-049787.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-049787 |
| 2026-03-31 | 20:05 ET | [10-K](/filings/0001104659-26-037701.md) | Annual report, period 2025-12-31 | 0001104659-26-037701 |
| 2026-02-12 | 21:05 ET | [8-K](/filings/0001104659-26-014267.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-014267 |
| 2026-01-23 | 21:05 ET | [8-K](/filings/0001104659-26-006233.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006233 |
| 2025-11-18 | 21:05 ET | [8-K](/filings/0001104659-25-113645.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-113645 |
| 2025-11-07 | 21:06 ET | [10-Q](/filings/0001104659-25-108475.md) | Quarterly report, period 2025-09-30 | 0001104659-25-108475 |
| 2025-09-29 | 20:22 ET | [8-K](/filings/0001104659-25-094507.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094507 |
| 2025-09-19 | 21:01 ET | [S-1](/filings/0001104659-25-091717.md) | Registration statement | 0001104659-25-091717 |
| 2025-08-18 | 13:00 ET | [8-K](/filings/0001558370-25-011625.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011625 |
| 2025-08-15 | 21:17 ET | [8-K](/filings/0001558370-25-011619.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001558370-25-011619 |
| 2025-08-14 | 20:05 ET | [10-Q](/filings/0001558370-25-011554.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011554 |
| 2025-07-31 | 20:18 ET | [8-K](/filings/0001104659-25-072708.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072708 |
| 2025-06-20 | 20:05 ET | [8-K](/filings/0001558370-25-008772.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008772 |
| 2025-05-09 | 20:05 ET | [10-Q](/filings/0001558370-25-007171.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007171 |
| 2025-05-05 | 20:05 ET | [DEF 14A](/filings/0001104659-25-044504.md) | Proxy statement, period 2025-06-20 | 0001104659-25-044504 |
| 2025-03-28 | 20:05 ET | [8-K](/filings/0001558370-25-003987.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-25-003987 |
| 2025-03-21 | 20:05 ET | [10-K](/filings/0001558370-25-003459.md) | Annual report, period 2024-12-31 | 0001558370-25-003459 |
| 2025-02-10 | 12:30 ET | [8-K](/filings/0001558370-25-000726.md) | 1.02 Termination of a material agreement | 0001558370-25-000726 |
| 2024-11-08 | 21:06 ET | [10-Q](/filings/0001558370-24-015054.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015054 |
| 2024-10-11 | 20:05 ET | [8-K](/filings/0001558370-24-013257.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001558370-24-013257 |
| 2024-08-16 | 20:13 ET | [8-K](/filings/0001558370-24-012345.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-012345 |
| 2024-08-09 | 20:05 ET | [10-Q](/filings/0001558370-24-011740.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011740 |
| 2024-07-25 | 11:30 ET | [8-K](/filings/0001558370-24-010107.md) | 1.01 Entry into a material agreement | 0001558370-24-010107 |
| 2024-07-24 | 21:28 ET | [S-1](/filings/0001558370-24-010061.md) | Registration statement | 0001558370-24-010061 |
| 2024-07-09 | 17:28 ET | [8-K](/filings/0001558370-24-009712.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001558370-24-009712 |
| 2024-05-31 | 12:00 ET | [8-K](/filings/0001558370-24-008803.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008803 |
| 2024-05-24 | 20:05 ET | [8-K](/filings/0001558370-24-008642.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008642 |
| 2024-05-17 | 20:25 ET | [8-K](/filings/0001558370-24-008421.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-008421 |
| 2024-05-10 | 20:05 ET | [10-Q](/filings/0001558370-24-007782.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007782 |
| 2024-04-29 | 20:01 ET | [DEF 14A](/filings/0001104659-24-053983.md) | Proxy statement, period 2024-05-23 | 0001104659-24-053983 |
| 2024-04-22 | 20:05 ET | [8-K](/filings/0001558370-24-005411.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-005411 |
| 2024-04-03 | 20:05 ET | [8-K](/filings/0001558370-24-004663.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-004663 |
| 2024-04-02 | 21:06 ET | [S-1/A](/filings/0001558370-24-004621.md) | Registration statement, amended | 0001558370-24-004621 |
| 2024-03-15 | 20:19 ET | [S-1/A](/filings/0001558370-24-003415.md) | Registration statement, amended | 0001558370-24-003415 |
| 2024-03-15 | 20:06 ET | [10-K](/filings/0001558370-24-003402.md) | Annual report, period 2023-12-31 | 0001558370-24-003402 |
| 2024-01-16 | 22:46 ET | [S-1](/filings/0001558370-24-000253.md) | Registration statement | 0001558370-24-000253 |
| 2023-12-22 | 21:05 ET | [8-K](/filings/0001558370-23-019993.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001558370-23-019993 |
| 2023-12-15 | 21:03 ET | [8-K](/filings/0001558370-23-019838.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-23-019838 |
| 2023-11-17 | 21:05 ET | [8-K](/filings/0001558370-23-019193.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019193 |
| 2023-11-13 | 21:00 ET | [10-Q](/filings/0001558370-23-018818.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018818 |
| 2023-10-20 | 20:05 ET | [8-K](/filings/0001558370-23-016573.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-016573 |
| 2023-09-22 | 20:05 ET | [8-K](/filings/0001558370-23-015942.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-015942 |
| 2023-09-15 | 20:05 ET | [8-K](/filings/0001558370-23-015812.md) | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-015812 |

Page 1 of 7. [Older](/companies/sngx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.